"Parkinson AKTIV - Non-pharmacological Treatments in an Innovative Parkinson's Network"

NCT05251298 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 370

Last updated 2023-04-20

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of an online platform that allows neurologists and therapists to exchange therapy recommendations, communicate assessments and plan physical therapy, occupational therapy as well as speech and swallowing therapy for their patients.

Conditions

  • Parkinson Disease

Interventions

OTHER

Coordination through the online platform "JamesAKTIV"

Coordination of the treatment through the online platform "JamesAKTIV" that allows neurologists and therapists to select specialised therapies for the predominant symptoms of the patients and communicate easily about problems during the treatment

Sponsors & Collaborators

  • privates Institut für angewandte Versorgungsforschung GmbH

    collaborator UNKNOWN
  • AOK PLUS

    collaborator INDUSTRY
  • University Hospital Muenster

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-28
Primary Completion
2024-03-31
Completion
2024-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05251298 on ClinicalTrials.gov